EVA MARÍA
CIRUELOS GIL
Profesora asociada de Ciencias de la Salud
Sunnybrook Health Science Centre
Toronto, CanadáPublicaciones en colaboración con investigadores/as de Sunnybrook Health Science Centre (3)
2024
-
Low RNA disruption during neoadjuvant chemotherapy predicts pathologic complete response absence in patients with breast cancer
JNCI Cancer Spectrum, Vol. 8, Núm. 1
2022
-
Correction to: Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population (Breast Cancer Research and Treatment, (2021), 189, 3, (689-699), 10.1007/s10549-021-06334-0)
Breast Cancer Research and Treatment
2021
-
Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population
Breast Cancer Research and Treatment, Vol. 189, Núm. 3, pp. 689-699